We use cookies to improve your browsing experience and provide meaningful content. Read our cookie policy. Accept
  •  Customer Login
  • Register
  •  View Cart (0)
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us

Clontech Takara Cellartis

Close

  • ‹ Back to Gene editing
  • Mouse CRISPR knockin protocol
Long ssDNA for CRISPR/Cas9 gene knockin experiments Long ssDNA for CRISPR/Cas9 gene knockin
Guide-it Recombinant Cas9 (Electroporation-Ready)
Miniprep kits for isolation of genomic DNA from tissue NucleoSpin Tissue
Home › Learning centers › Gene function › Gene editing › Mouse CRISPR knockin protocol

  • SNP engineering webinar
New products
Need help?
Contact Sales
Long ssDNA for CRISPR/Cas9 gene knockin experiments Long ssDNA for CRISPR/Cas9 gene knockin
Guide-it Recombinant Cas9 (Electroporation-Ready)
Miniprep kits for isolation of genomic DNA from tissue NucleoSpin Tissue
User-generated protocol

Mouse genome engineering made simple: ex vivo RNP-ssDNA microinjection protocol for precise editing

  • Long ssDNA is used as a homology-directed repair (HDR) template for mouse genome engineering
  • ssDNA templates prepared with the kit can be used directly in the microinjection mixture
  • A high accuracy of gene knockins can be achieved with this protocol

Featured product: Guide-it Long ssDNA Production System

The development and refinement of CRISPR genome editing technology have provided researchers with a more efficient, streamlined, and faster approach for generating knockin mouse models as compared to classical gene targeting. The following protocol, generously provided by Dr. Benedikt Wefers, Laboratory Head at the German Center for Neurodegenerative Diseases (DZNE), employs ex vivo microinjection of Cas9-guide RNA (crRNA:tracrRNA duplex) ribonucleoproteins (RNPs) in tandem with long ssDNA templates for homology-directed repair (HDR) into mouse zygotes. Using this approach, Dr. Wefers and colleagues were able to achieve efficient insertion of a fluorescent protein in frame to an endogenous gene, as demonstrated by the corresponding application data.

Workflow Materials Protocol Genotyping References

Workflow  

CRISPR-mediated engineering of mouse knockins was performed using the workflow described by the following figure:

Figure 1. Workflow for efficient genome engineering via ex vivo microinjection of mouse embryos at the one-cell stage. First, the CRISPR editing components (Cas9/sgRNA [crRNA:tracrRNA duplex]), RNP complex, and ssDNA HDR templates are prepared. The CRISPR components are then microinjected into one-day-old mouse zygotes and transferred to pseudopregnant foster mothers. Seven weeks after microinjection, biopsy samples are collected from the pups derived from the microinjected zygotes. The genotyping step includes two rounds of PCR with primers designed to confirm whether the knockin insertions are complete and there are no truncations or duplications. Finally, the DNA from positive founders are sequenced by Sanger sequencing.

Materials  

  • Microinjection buffer (T10 E0.1 buffer) (10 mM Tris-HCl and 0.1 mM EDTA prepared with sterile filtered, embryo-tested water; e.g., Millipore Sigma, Cat. # W1503)
  • Target-specific crRNA and tracrRNA (each stock 100 µM, suspended in microinjection buffer [T10 E0.1 buffer]; alternatively, in vitro-transcribed or synthesized single-guide RNA [sgRNA] can be used)
  • SpCas9 protein (1 µg/µl working stock diluted in SpCas9 dilution buffer and stored at –20°C)
  • SpCas9 dilution buffer (300 mM NaCl, 10 mM Tris-HCl, 1 mM DTT, 0.1 mM EDTA, 500 µg/ml BSA, and 50% glycerol prepared in embryo-tested water, pH 7.4 at 25°C) (NEB, Cat. # B8002S)
  • Single-stranded DNA (ssDNA) HDR template generated using the Guide-it Long ssDNA Production System (Cat. # 632644)
  • Urea-containing loading dye (e.g., Novex TBE-Urea Sample Buffer (2X), Thermo Fisher, Cat. # LC6876)
  • Centrifugal filters (low-protein-binding PVDF membrane; e.g., Ultrafree-MC Centrifugal Filter, Millipore Sigma, Cat. # UFC30VV25)
  • Certified sterile, nuclease-free 0.5-ml microcentrifuge tubes (e.g., Eppendorf Snap-Cap Microcentrifuge Biopur Safe-Lock Tubes, Thermo Fisher, Cat. # 022600001)
  • Materials needed for microinjection and embryo transfer (please see Wefers et al. 2017 for details)

Protocol  

This protocol is for the generation of transgenic knockin mice containing a fluorescent protein in frame with an endogenous gene separated by a P2A signal. Gene editing was performed on one-day-old mouse zygotes via microinjection of the RNP complex together with a 1,200-nt long ssDNA HDR template encoding the insert sequence (~800 nt) flanked on either side by homology arms of ~200 nt.

Preparation of editing reagents

  1. Preparation of ssDNA HDR template

    1. Preparation of dsDNA substrate by PCR

      The dsDNA substrate was generated by PCR using a forward and a reverse primer complementary to the donor template. The reverse primer was designed with a 5' phosphorylation allowing for the generation of the ssDNA encoding the sense strand in the next step.

      PCR reaction: Cycling conditions:
      50 µl PrimeSTAR Max Premix (2X) 98°C 10 sec



      40 cycles

      40 ng Template DNA (encoding for HDR template) 55°C 5 sec
      2 µl Forward primer 72°C 15 sec
      2 µl Reverse primer (5' phosphorylated)
      X µl RNase-Free Water
      100 µl Total volume

      The specificity and yield of the PCR product were confirmed by agarose gel electrophoresis prior to further processing (Figure 2, Panel A). The PCR product was column purified, yielding approximately 10.7 µg of dsDNA.

    2. Generation of ssDNA

      To generate ssDNA, the PCR product obtained in the previous step was subjected to two short, consecutive strandase reactions (Strandase A and Strandase B) to yield ssDNA as specified by the kit protocol, using the conditions indicated below.

      Strandase A reaction: Incubate as follows:
      10 µg dsDNA substrate 37°C   6 min (5 min/kb)
      80°C   5 min
      4°C     until next step
      5 µl Strandase A Buffer (10X)
      5 µl Strandase Mix A
      X µl RNAase-Free Water
      50 µl Total volume
      Strandase B reaction (processing Strandase A reaction mixture): Incubate as follows:
      50 µl Strandase A reaction mixture 37°C   6 min (5 min/kb)
      80°C   5 min
      4°C     until next step
      50 µl Strandase B Buffer (2X)
      1 µl Strandase Mix B
      101 µl Total volume

      The ssDNA generated from the Strandase B reaction above was purified using the NucleoSpin Gel and PCR Clean-Up kit (supplied with the ssDNA kit) and eluted in 30 µl of the microinjection buffer (in substitution of the standard NE buffer provided by the kit). The ssDNA concentration was measured by NanoDrop spectrophotometry (1 OD260 = 33 ng/µl) and was approximately 66 ng/µl (total yield of ~2 µg).

      NOTE: The ssDNA is eluted directly from the DNA purification column using microinjection buffer, allowing the direct use of the ssDNA for microinjection after purification.

    3. Quality control of ssDNA template

      Following purification of the strandase reactions, the successful production of ssDNA HDR templates was confirmed via two different methods:

      Agarose gel electrophoresis:

      Strandase products were treated with urea-containing loading dye at 95°C for 5 min to eliminate secondary structures prior to electrophoresis and were run side-by-side with corresponding undigested dsDNA PCR products for size comparison purposes on a 1.5% TAE agarose gel using 0.005% (v/v) SERVA HiSens Stain G (Figure 2, Panel B, below).

      Figure 2. Production of ssDNA HDR template. Panel A. Analysis of the dsDNA PCR template prior to strandase digestion. Left lane: 1-kb ladder; Lane 1: dsDNA PCR amplification product. Panel B. Analysis of ssDNA product following strandase treatment and purification. Left lanes: 100-bp ladder; 1-kb ladder. Lane 1: dsDNA (1,206 bp, 100 ng); Lane 2: sense ssDNA (200 ng); Lane 3: RiboRuler ladder.

      Sanger sequencing:

      To confirm that the strandase treatment did not result in truncation of the generated ssDNA and that there was no trace of dsDNA, three independent sequencing reactions were performed with different annealing primers:

      • The reverse primer used in the PCR (Section 1.A) to sequence the end of the right homology arm (the sequencing would fail if the right arm is truncated)
      • Internal reverse primer running upstream to the PCR forward primer to sequence the end of the left homology arm
      • Internal forward primer running downstream and complementary to the antisense strand which should fail if there is no trace of dsDNA

      The sequencing results indicated that there was no obvious size reduction or presence of dsDNA (data not shown).

  2. Preparation of microinjection aliquots containing the editing reagents

    Aliquots of the microinjection reagents (containing the editing components) can be prepared beforehand and stored at –80°C until use. One injection capillary (filled with 3 µl of the microinjection mix) can be used to inject >100 embryos at once; however, sometimes capillaries break or get clogged. Therefore, it is advisable to prepare single-use, 10-µl aliquots of the reagents to have enough to fill two new capillaries for each session of microinjections.

    NOTE: Pronuclear injection efficiency is variable from day to day (due to the yield of embryo collection, implantation of embryos in fosters, number of pups born, etc.). Therefore, it is advisable to inject on several days to ensure a sufficient number of pups (and consequently pups carrying the desired edit). Since identical microinjection aliquots are used on 2–3 different injection days, the aliquot mix might be scaled up by 2–3 fold and frozen in 10-µl single-use aliquots. This will reduce variation between the aliquots and their degradation due to repeated freeze/thaw cycles.

    1. Preparation of crRNA:tracrRNA mix
      1. Combine the following in a sterile, nuclease-free microcentrifuge tube:
        • 1 µl   crRNA (10 µM)
        • 1 µl   tracrRNA (10 µM)
        • 8 µl   microinjection buffer
      2. Incubate the crRNA:tracrRNA mix in a thermal cycler running the following program:
        • 95°C 5 min
        • Cool to 25°C (decrease temperature at a rate of –5°C/min)
      3. Store mix on ice until use.
    2. Preparation of pronuclear injection (PNI) aliquot mix
      1. Prepare a 10-µl aliquot of microinjection mix for each PNI day/session in a sterile, nuclease-free microcentrifuge tube as shown below, and incubate the mixture at RT for 15 min.

        NOTE: Scale up according to the total number of PNI day/sessions as explained in the previous section.

        Reagent Volume per aliquot Concentration (stock) Concentration (final)
        crRNA:tracrRNA mix (previous section) 0.6 µl 10 µM 0.6 µM
        SpCas9 protein 0.3 µl 1 µg/µl (6.1 µM) 30 ng/µl (0.2 µM)
        Microinjection buffer (T10E0.1) 9.1 – X µl* – –

        *The amount of microinjection buffer (T10E0.1) included per aliquot varies depending on the volume of ssDNA template (X) added following the 15-min incubation (Step 2, below).

      2. After incubation, add X µl of ssDNA (or single-stranded donor oligonucleotides, ssODN) template per 10 µl aliquot to obtain a final concentration of 10 ng/µl. For example, in the case of an ssDNA with a stock concentration of 66 ng/µl, add 1.5 µl of ssDNA and 7.6 µl of microinjection buffer.

        NOTE: If an ssODN (<200 nt) is injected, its final concentration must be 25 ng/µl.

      3. Filter the PNI aliquot mix using a centrifugal filter for 2 min at 12,000g.
      4. Transfer 10-µl aliquots of PNI mix into separate 0.5-ml microcentrifuge tubes.
      5. Store aliquots at –80°C until the day of injection.
  3. Microinjection and implantation of mouse embryos

    On the day of injection:

    1. Thaw PNI aliquots on ice.
    2. Spin the aliquots for 5 min at 20,000g.
    3. Transfer 9.5 µl of supernatant from each aliquot to a fresh, nuclease-free 0.5-ml microcentrifuge tube.
    4. Keep isolated supernatant from PNI aliquot on ice until injection.

For the exact procedure of the microinjection and implantation of mouse embryos, please follow the protocol explained in Wefers et al. 2017.

Genotyping  

Seven weeks after microinjection and implantation of the embryos, genotyping was performed on the F0 founders via both PCR analysis and Sanger sequencing of the genomic target region.

The first round of genotyping consisted of three independent PCR reactions (Figure 3, Panel A) designed to amplify the junctions between the targeted sequence and insert (Out-In/Fw 1-Rev 1 and In-Out/Fw 2-Rev 2) as well as the whole insert sequence (In-In/Fw 2-Rev 1). The correct band amplification in all three PCR reactions confirms the presence of the insert and its correct orientation.

Figure 3, Panel B shows a representative agarose gel of samples analyzed using the primer pair Out-In/Fw 1-Rev 1. The analysis identified founders carrying full-length insertions at the correct genomic locus and in the correct orientation (Founders 2, 4, and 6) as well as other founders carrying truncated inserts (Founders 1 and 3).

From the positive samples (F0 mice) identified from the first PCR, a second round of PCR genotyping was performed using the primer set Fw 1-Rev 2 (Out-Out). These primers anneal outside the homology arms and help confirm whether the entire insert sequence was incorporated successfully without any truncations or duplications. A representative agarose gel of samples analyzed using this primer pair Out-Out/Fw 1-Rev 2 is presented below (Figure 3, Panel C).

Samples that tested positive for successful integration of the insert were then confirmed by Sanger sequencing of both the 5' and 3' junctions. The final genotyping results are shown in Table I. Overall, 48% of the pups were born with a knockin and from this subpopulation, 70% had a correct insertion of the sequence encoding for the fluorescent protein.

Figure 3. PCR genotyping experiment and results. Different sets of primers were used to identify the founders (F0) carrying the correct insertion of the fluorescent protein at the target site. Panel A. The locations of the primers and the expected amplicon sizes for the four different PCR reactions. Panel B. Representative results for Out-In/Fw 1-Rev 1 PCR. Lanes are marked with founder numbers and correspond to amplicon sizes of ~510 bp (Founder 1), 1,054 bp (Founders 2, 4, and 6), ~880 bp (Founder 3); PC: positive control; NTC: no template control. Panel C. Example of results for Out-Out/Fw 1-Rev 2 PCR. Lane 1: 1-kb ladder; Lane 2: positive founder; Lane 3: WT control; Lane 4: no template control; Lane 5: 100-bp ladder.

Total # of pups born # of pups positive for insertion # of pups carrying complete insert
21 10* (48% of total) 7 (33% of total)

Table I. Summary of the genotyping analysis of F0. *One of the knockins involved concatemerization of the insert, and the other two involved a truncation.

References  

Wefers, B., Bashir, S., Rossius, J., Wurst, W., & Kühn, R. Gene editing in mouse zygotes using the CRISPR/Cas9 system. Methods 121, 55–67 (2017).

Related Products

Cat. # Product Size Price License Quantity Details
632636 Guide-it™ Complete sgRNA Screening System 50 Rxns USD $1056.00

License Statement

ID Number  
M54 This product is covered by the claims of U.S. Patent Nos. 7,704,713 and its foreign counterparts. 
272 This product (“Product”) and its use, is the subject of U.S. Patents 8,697,359 and 8,771,945 and pending U.S. Patent applications. The purchase of the Product conveys to the buyer the non-transferable right to use Product(s) purchased from Takara Bio USA, Inc. or its Affiliates, and any progeny, modification or derivative of a Product, or any cell or animal made or modified through use of a Product, or any progeny, modification or derivative of such cell or animal (“Related Material”), solely for research conducted by the buyer in accordance with all of the following requirements. No right is given to use this Product or Related Material for any other purpose, including, but not limited to, use in drugs, in vitro diagnostic purposes, therapeutics, or in humans. (i) The buyer shall not sell or otherwise transfer Products (including without limitation any material that contains a Licensed Product in whole or part) or any Related Material to any other person or entity, or use Products or any Related Material to perform services for the benefit of any other person or entity, (ii) the buyer shall use only the purchased amount of the Products and components of the Products, and shall use any Related Material, only for its internal research and not for (a) the practice, performance or provision of any method, process or service, or (b) the manufacture, sale, use, distribution, disposition or importing of any product, in each case (a) or (b) for consideration, or on any other commercial basis (“Commercial Purpose”), (iii) the buyer shall use Licensed Products and any Related Material in compliance with all applicable laws and regulations, including without limitation applicable human health and animal welfare laws and regulations, and (iv) the buyer shall indemnify, defend and hold harmless MIT, Harvard and The Broad and their current and former trustees, directors, officers, faculty, affiliated investigators, students, employees, and agents and their respective successors, heirs and assigns (“Indemnitees”), against any liability, damage, loss, or expense (including without limitation reasonable attorneys’ fees and expenses) incurred by or imposed upon any of the Indemnitees in connection with any claims, suits, investigations, actions, demands or judgments arising out of or related to the exercise of any rights granted to the buyer, or any breach of the rights granted hereunder by the buyer.
391 LIMITED USE LABEL LICENSE: RESEARCH USE ONLY Notice to Purchaser: This product is the subject to a license granted to Takara Bio USA, Inc. and its Affiliates from Caribou Biosciences, Inc., and this product is transferred to the end-user purchaser (“Purchaser”) subject to a “Limited Use Label License” conveying to the Purchaser a limited, non-transferable right to use the product, solely as provided to Purchaser, together with (i) progeny or derivatives of the product generated by the Purchaser (including but not limited to cells), and (ii) biological material extracted or derived from the product or its corresponding progeny or derivatives (including but not limited to cells) (collectively, the product, and (i) and (ii) are referred to as (“Material”) only to perform internal research for the sole benefit of the Purchaser. The Purchaser cannot sell or otherwise transfer Material to a third party or otherwise use the Material for any Excluded Use. “Excluded Use” means any and all: (a) commercial activity including, but not limited to, any use in manufacturing (including but not limited to cell line development for purposes of bioproduction), product testing, or quality control; (b) preclinical or clinical testing or other activity directed toward the submission of data to the U.S. Food and Drug Administration, or any other regulatory agency in any country or jurisdiction where the active agent in such studies comprises the Material; (c) use to provide a service, information, or data to a third party; (d) use for human or animal therapeutic, diagnostic, or prophylactic purposes or as a product for therapeutics, diagnostics, or prophylaxis; (e) activity in an agricultural field trial or any activity directed toward the submission of data to the U.S. Department of Agriculture or any other agriculture regulatory agency; (f) high throughput screening drug discovery purposes (i.e., the screening of more than 10,000 experiments per day) as well as scale-up production activities for commercialization; (g) modification of human germline, including editing of human embryo genomes (with the sole exception of editing human embryonic stem (ES) cell lines for research purposes) or reproductive cells; (h) self-editing; and/or (i) stimulation of biased inheritance of a particular gene or trait or set of genes or traits (“gene drive”). It is the Purchaser’s responsibility to use the Material in accordance with all applicable laws and regulations. For information on obtaining additional rights, including commercial rights, please contact licensing@cariboubio.com or Caribou Biosciences, Inc., 2929 7th Street, Suite 105, Berkeley, CA 94710 USA, Attn: Licensing.
396 Sigma-Aldrich CRISPR Use License Agreement This Product and its use are the subject of one or more of the following issued patents and patent applications: Australia Patent Nos. 2013355214; 2017204031; and 2018229489; Canada Patent Nos. 2,891,347 and 2,977,152; China Patent No. CN105142669; European Patent Nos. EP 2 928 496 B1; EP 3 138 910 B1, 3 138 911 B1, EP 3 138 912 B1, EP 3 360 964 B1, EP 3 363 902 B1; Israel Patent No. IL238856; Singapore Patent No. 11201503824S; South Korea Patent Nos. 10-1844123 and 10-2006880; and U.S. Patent Application Serial Nos. 15/188,911; 15/188,924; 15/188,927; 15/188,931; and 15/456,204 (the “Patent Rights”). The purchase of this Product conveys to you (the “Buyer”) the NON-TRANSFERABLE right to use the Product for Licensed Research Use (see definition below) subject to the conditions set out in this License Agreement. 1. “Licensed Research Use” means any use for research purposes, except: (i) Buyer may not sell or otherwise transfer the Product (including without limitation any material that contains the Product in whole or part) or any Related Material to any other third party (except that you may transfer the Product, or any Related Material to a bona fide collaborator or contract research organization), or use the Products or any Related Material to perform services for the benefit of any other third party; (ii) Buyer may use only the purchased amount of the Product and components of the Product, and shall use any Related Material, only for your internal research within the Field, and not for any Commercial Purposes; (iii) Buyer shall use the Product and any Related Material in compliance with all applicable laws and regulations, including without limitation applicable human health and animal welfare laws and regulations; and (iv) the Buyer shall indemnify, defend, and hold harmless SIGMA and their current and former directors, officers, employees and agents, and their respective successors, heirs and assigns (the “Indemnities”) against any liability, damage, loss, or expense (including without limitation reasonable attorneys’ fees and expenses) incurred by or imposed upon any of the Indemnitees in connection with any claims, suits, investigations, actions, demands or judgments arising out of or related to the exercise of any rights granted to the Buyer hereunder or any breach of this License Agreement by such Buyer. 2. For purposes of Section 1 above, the following definitions shall apply: “Commercial Purposes” means (a) the practice, performance or provision of any method, process or service, or (b) the manufacture, sale, use, distribution, disposition or importing of any product, in each case (a) or (b) for consideration, or on any other commercial basis. “Field” means use as a research tool for research purposes; provided, however, that notwithstanding the foregoing, the Field shall expressly exclude (a) any in vivo and ex vivo human or clinical use, including, without limitation, any administration into humans or any diagnostic or prognostic use, (b) the creation of transgenic rodent models and/or derivatives thereof (including, but not limited to, rodents’ cells and rodents’ organs) by for-profit entities, (c) any in vivo veterinary or livestock use, or non-research agricultural use, or (d) use as a testing service, therapeutic or diagnostic for humans or animals. “Related Materials” means any progeny, modification or derivative of a Product. 3. Your right to use the Product will terminate immediately if you fail to comply with these terms and conditions. You shall, upon such termination of your rights, destroy all Product, Related Materials, and components thereof in your control, and notify SIGMA of such in writing. For information on purchasing a license to this Product for purposes other than Licensed Research Use, contact your local SIGMA sales representative, or call +1 800-325-3010.

The Guide-it Complete sgRNA Screening System includes everything needed for the simple production, cleanup, and evaluation of single guide RNAs (sgRNAs) for CRISPR/Cas9 studies, including PCR reagents for amplifying your genomic target and recombinant Cas9 for in vitro analysis of the transcribed sgRNA.

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Components Image Data

Back

Production of sgRNA by in vitro transcription and testing for cleavage using recombinant Cas9 protein

Production of sgRNA by in vitro transcription and testing for cleavage using recombinant Cas9 protein
Schematic highlighting the key steps for using Guide-it kits for the production of high amounts of single guide RNA (sgRNA) and screening for target site cleavage efficacy using recombinant Cas9 protein.

Back

sgRNA yield and quality for different gene targets using the Guide-it Complete sgRNA Screening System

sgRNA yield and quality for different gene targets using the Guide-it Complete sgRNA Screening System
sgRNA yield and quality for different gene targets using the Guide-it Complete sgRNA Screening System. Panel A. 20 µl of each sgRNA in vitro transcription (IVT) reaction was incubated for 4 hr at 37°C. The yield for each transcribed sgRNA was quantified using a NanoDrop spectrophotometer. Panel B. Each sgRNA IVT reaction was a run on an Agilent Bioanalyzer to assay for sample quality.

Back

sgRNA quality produced via in vitro transcription

sgRNA quality produced via in vitro transcription
sgRNA quality produced via in vitro transcription. sgRNAs produced using the Guide-it sgRNA In Vitro Transcription Kit were compared with sgRNAs produced using a competitor’s kit. The Guide-it kit produced a high-quality, single band for each reaction, while the competitor’s kit showed unwanted byproducts.

Back

Flow chart describing how the Guide-it sgRNA In Vitro Transcription Kit (including the Guide-it IVT RNA Clean-Up Kit) and Guide-it sgRNA Screening Kit work together in the Guide-it Complete sgRNA Screening System, which can be used to synthesize and test the efficacy of sgRNAs

Flow chart describing how the Guide-it sgRNA In Vitro Transcription Kit (including the Guide-it IVT RNA Clean-Up Kit) and Guide-it sgRNA Screening Kit work together in the Guide-it Complete sgRNA Screening System, which can be used to synthesize and test the efficacy of sgRNAs
Flow chart describing how the Guide-it sgRNA In Vitro Transcription Kit (including the Guide-it IVT RNA Clean-Up Kit) and Guide-it sgRNA Screening Kit work together in the Guide-it Complete sgRNA Screening System, which can be used to synthesize and test the efficacy of sgRNAs.
740952.50 NucleoSpin® Tissue 50 Preps Inquire for Quotation *

NucleoSpin Tissue (50) 50 preps for the isolation of genomic DNA from tissue - NucleoSpin Tissue Columns, Collection Tubes, buffers, Proteinase K

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents You May Also Like Image Data

Back

Typical yields of pure genomic DNA from NucleoSpin Tissue range from 15–25 µg

Typical yields of pure genomic DNA from NucleoSpin Tissue range from 15–25 µg

Typical yields of pure genomic DNA from NucleoSpin Tissue range from 15–25 µg. Up to 35 µg of pure genomic DNA can be prepared from two 0.5-cm mouse tail tip sections.

Back

The NucleoSpin Tissue procedure

The NucleoSpin Tissue procedure

The NucleoSpin Tissue procedure.

Back

740952.50: NucleoSpin Tissue

740952.50: NucleoSpin Tissue
740100.50 NucleoSpin® DNA RapidLyse 50 Preps Inquire for Quotation *

The NucleoSpin DNA RapidLyse kit is designed for fast and efficient isolation of genomic DNA from cells and organs like liver, kidney, heart, muscle, spleen, and lung. Processing of mouse tail and ear clippings is also possible. Fresh, frozen, and ethanol- preserved samples can be used.

Notice to purchaser

Our products are to be used for Research Use Only. They may not be used for any other purpose, including, but not limited to, use in humans, therapeutic or diagnostic use, or commercial use of any kind. Our products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without our prior written approval.

Documents Image Data

Back

740100.50: NucleoSpin DNA RapidLyse

740100.50: NucleoSpin DNA RapidLyse

*You must be logged in to a Purchasing Account in order to purchase these products online, since the purchase of these products may be restricted depending on your account type. Researchers at not-for-profit accounts receive a limited use license with their purchase of the product. Researchers at for-profit accounts must obtain a license prior to purchase. For details please contact licensing@takarabio.com.


User-generated protocols

User-generated protocols

User-generated protocols are based on internal proof-of-concept experiments, customer collaborations, and published literature. In some cases, relevant results are discussed in our research news BioView blog articles. While we expect these protocols to be successful in your hands, they may not be fully reviewed or optimized. We encourage you to contact us or refer to the published literature for more information about these user-generated and -reported protocols. 

If you are looking for a product-specific, fully optimized User Manual or Protocol-At-A-Glance, please visit the product's product page, open the item's product details row in the price table, and click Documents. More detailed instructions for locating documents are available on our website FAQs page.

Questions? Protocols of your own that you would like to share?

Contact technical support Give feedback

Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2025 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.

Takara Bio

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES (EXCEPT AS SPECIFICALLY NOTED).

Support
  • Contact us
  • Technical support
  • Customer service
  • Shipping & delivery
  • Sales
  • Feedback
Products
  • New products
  • Special offers
  • Instrument & reagent services
Learning centers
  • NGS
  • Gene function
  • Stem cell research
  • Protein research
  • PCR
  • Cloning
  • Nucleic acid purification
About
  • Our brands
  • Careers
  • Events
  • Blog
  • Need help?
  • Announcements
  • Quality and compliance
  • That's Good Science!
Facebook Twitter  LinkedIn

logo strip white

©2025 Takara Bio Inc. All Rights Reserved.

Region - North America Privacy Policy Terms and Conditions Terms of Use

Top



  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISAs
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • New products
  • Special offers
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing services
  • Services
  • Facilities
  • Our process
  • Resources
  • Customer service
  • Sales
  • Make an appointment with your sales rep
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • GoStix Plus FAQs
  • Partnering & Licensing
  • Vector information
  • Vector document overview
  • Vector document finder
Takara Bio's award-winning GMP-compliant manufacturing facility in Kusatsu, Shiga, Japan.

Partner with Takara Bio!

Takara Bio is proud to offer GMP-grade manufacturing capabilities at our award-winning facility in Kusatsu, Shiga, Japan.

  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Spatial biology
  • Trekker FAQs
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • Antibodies and ELISA
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • ESM partnership program
  • ESM Collection Kit forms
  • Infectious diseases
  • Develop vaccines for HIV
Create a web account with us

Log in to enjoy additional benefits

Want to save this information?

An account with takarabio.com entitles you to extra features such as:

•  Creating and saving shopping carts
•  Keeping a list of your products of interest
•  Saving all of your favorite pages on the site*
•  Accessing restricted content

*Save favorites by clicking the star () in the top right corner of each page while you're logged in.

Create an account to get started

  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Our brands
  • Our history
  • In the news
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • Trademarks
  • License statements
  • Quality statement
  • HQ-grade reagents
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
  • Website FAQs

That's GOOD Science!

What does it take to generate good science? Careful planning, dedicated researchers, and the right tools. At Takara Bio, we thoughtfully develop exceptional products to tackle your most challenging research problems, and have an expert team of technical support professionals to help you along the way, all at superior value.

Explore what makes good science possible

 Customer Login
 View Cart (0)
Takara Bio
  • Home
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES (EXCEPT AS SPECIFICALLY NOTED).

Clontech, TaKaRa, cellartis

  • Products
  • COVID-19 research
  • Next-generation sequencing
  • Real-time PCR
  • Stem cell research
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Nucleic acid purification
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • New products
  • Special offers
  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISA
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • Services & Support
  • OEM
  • Instrument services
  • Gene and cell therapy manufacturing
  • Customer service
  • Sales
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • Partnering & Licensing
  • Vector information
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing
  • Services
  • Facilities
  • Our process
  • Resources
  • Sales
  • Make an appointment with your sales rep
  • Online tools
  • GoStix Plus FAQs
  • Vector information
  • Vector document overview
  • Vector document finder
  • Learning centers
  • Automation systems
  • Next-generation sequencing
  • Spatial biology
  • Real-time PCR
  • Nucleic acid purification
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Stem cell research
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Spatial biology
  • Trekker FAQs
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • APPLICATIONS
  • Molecular diagnostics
  • mRNA and protein therapeutics
  • Pathogen detection
  • Immunotherapy research
  • Cancer research
  • Alzheimer's disease research
  • Reproductive health technologies
  • Infectious diseases
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • ESM partnership program
  • ESM Collection Kit forms
  • Infectious diseases
  • Develop vaccines for HIV
  • About
  • BioView blog
  • That's Good Science!
  • Our brands
  • Our history
  • In the news
  • Events
  • Careers
  • Trademarks
  • License statements
  • Quality and compliance
  • HQ-grade reagents
  • International Contacts by Region
  • Need help?
  • Website FAQs
  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us